全文获取类型
收费全文 | 40075篇 |
免费 | 2098篇 |
国内免费 | 154篇 |
专业分类
耳鼻咽喉 | 522篇 |
儿科学 | 2589篇 |
妇产科学 | 704篇 |
基础医学 | 4782篇 |
口腔科学 | 1117篇 |
临床医学 | 2885篇 |
内科学 | 7173篇 |
皮肤病学 | 1135篇 |
神经病学 | 2354篇 |
特种医学 | 1314篇 |
外科学 | 5994篇 |
综合类 | 1293篇 |
一般理论 | 17篇 |
预防医学 | 2033篇 |
眼科学 | 1429篇 |
药学 | 3994篇 |
1篇 | |
中国医学 | 349篇 |
肿瘤学 | 2642篇 |
出版年
2023年 | 326篇 |
2022年 | 954篇 |
2021年 | 1604篇 |
2020年 | 880篇 |
2019年 | 969篇 |
2018年 | 1376篇 |
2017年 | 1002篇 |
2016年 | 1325篇 |
2015年 | 1336篇 |
2014年 | 1958篇 |
2013年 | 2223篇 |
2012年 | 3108篇 |
2011年 | 3036篇 |
2010年 | 1841篇 |
2009年 | 1457篇 |
2008年 | 2043篇 |
2007年 | 2077篇 |
2006年 | 1888篇 |
2005年 | 1679篇 |
2004年 | 1561篇 |
2003年 | 1320篇 |
2002年 | 1131篇 |
2001年 | 788篇 |
2000年 | 712篇 |
1999年 | 589篇 |
1998年 | 283篇 |
1997年 | 248篇 |
1996年 | 239篇 |
1995年 | 206篇 |
1994年 | 170篇 |
1993年 | 136篇 |
1992年 | 353篇 |
1991年 | 336篇 |
1990年 | 365篇 |
1989年 | 342篇 |
1988年 | 294篇 |
1987年 | 256篇 |
1986年 | 243篇 |
1985年 | 238篇 |
1984年 | 179篇 |
1983年 | 131篇 |
1982年 | 75篇 |
1981年 | 84篇 |
1980年 | 81篇 |
1979年 | 110篇 |
1978年 | 75篇 |
1977年 | 94篇 |
1976年 | 73篇 |
1975年 | 61篇 |
1973年 | 62篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
993.
Mohit Girotra Vivek Kumar Javaid M. Khan Pamela Damisse Rtika R. Abraham Vikas Aggarwal Sudhir K. Dutta 《Saudi Journal Of Gastroenterology》2012,18(2):133-139
Background/Aim:
Clostridium difficile infection (CDI) can affect up to 8% of hospitalized patients. Twenty-five percent CDI patients may develop C. difficile associated diarrhea (CDAD) and 1–3% may progress to fulminant C. difficile colitis (FCDC). Once developed, FCDC has higher rates of complications and mortality.Patients and Methods:
A 10-year retrospective review of FCDC patients who underwent colectomy was performed and compared with randomly selected age- and sex-matched non-fulminant CDAD patients at our institution. FCDC (n=18) and CDAD (n=49) groups were defined clinically, radiologically, and pathologically. Univariate analysis was performed using Chi-square and Student''s t test followed by multivariate logistic regression to compute independent predictors.Results:
FCDC patients were significantly older (77 ± 13 years), presented with triad of abdominal pain (89%), diarrhea (72%), and distention (39%); 28% had prior CDI and had greater hemodynamic instability. In contrast, CDAD patients were comparatively younger (65 ± 20 years), presented with only 1 or 2 of these 3 symptoms and only 5% had prior CDI. No significant difference was noted between the 2 groups in terms of comorbid conditions, use of antibiotics, or proton pump inhibitor. Leukocytosis was significantly higher in FCDC patients (18.6 ± 15.8/mm3 vs 10.7 ± 5.2/mm3; P=0.04) and further increased until the point of surgery. Use of antiperistaltic medications was higher in FCDC than CDAD group (56% vs 22%; P=0.01).Conclusions:
Our data suggest several clinical and laboratory features in CDI patients, which may be indicative of FCDC. These include old age (>70 years), prior CDI, clinical triad of increasing abdominal pain, distention and diarrhea, profound leukocytosis (>18,000/mm3), hemodynamic instability, and use of antiperistaltic medications. 相似文献994.
995.
996.
997.
Duong JK Roberts DM Furlong TJ Kumar SS Greenfield JR Kirkpatrick CM Graham GG Williams KM Day RO 《Diabetes, obesity & metabolism》2012,14(10):963-965
Metformin therapy is limited in patients with chronic kidney disease (CKD) due to the potential risk of lactic acidosis. This open‐label observational study investigated metformin and lactate concentrations in patients with CKD (n = 22; creatinine clearances 15–40 ml/min) and in two dialysed patients. Patients were prescribed a range of metformin doses (250–2000 mg daily) and metformin concentrations were compared with data from healthy subjects (scaled to 1500 mg twice daily). A subset of patients (n = 7) was controlled on low doses of metformin (250 or 500 mg daily). No correlation between metformin and lactate concentrations was observed. Three patients had high lactate concentrations (>2.7 mmol/l) and two had high metformin concentrations (3–5 mg/l), but none had any symptoms of lactic acidosis. Reducing metformin dosage and monitoring metformin concentrations will allow the safe use of metformin in CKD, provided that renal function is stable. 相似文献
998.
999.
1000.